S100A1 and ductal breast carcinoma in situ: Finally, raw microarray data from a previous clinical study39 consisting 5 healthy and 9 ductal carcinoma in situ (DCIS) patient tissue samples was analyzed to identify S100 genes that are differentially expressed during the early stages of breast cancer development.